FDA approves Remdesivir for COVID-19 despite WHO study showing no benefit. (Photo: AP)
Washington, October 24 (RHC)-- The U.S. Food and Drug Administration has approved Remdesivir as the first COVID-19 treatment in the United States.
Some studies have shown the antiviral drug may reduce the number of days COVID-19 patients are hospitalized, although a large World Health Organization study published last week found Remdesivir fails to prevent deaths among COVID-19 patients.
